Meta Pixel

Bradesco to Consolidate Health Units Under Odontoprev in Strategic Overhaul

Restructuring would turn Odontoprev into “Bradsaúde” and centralize Bradesco’s full healthcare ecosystem, boosting scale, cross-selling and capital efficiency.

By Brazil Stock Guide – Banco Bradesco (B3: BBDC3, BBDC4) unveiled a sweeping health-sector reorganization that will create Bradsaúde, a consolidated healthcare ecosystem that will be listed on Novo Mercado, Brazil’s highest corporate governance segment. The new platform will bring together insurance, hospitals, clinics and health technology assets under one listed vehicle and is set to debut with R$ 52 billion in revenue, R$ 3.6 billion in net income and 24% return on equity, based on consolidated 2025 figures.

The conglomerate will serve more than 13 million beneficiaries, operate alongside approximately 3,600 hospital beds under contract or development, and include a network of 35 primary-care clinics, positioning Bradsaúde as the most vertically integrated platform in Brazil’s supplementary healthcare market.

The restructuring consolidates Bradesco Saúde, Odontoprev, Mediservice, Atlântica Hospitais e Participações, Orizon, Meu Doutor Novamed and oncology investments through Croma Oncologia, in addition to a 25% stake in diagnostics group Fleury. Odontoprev will be renamed Bradsaúde and transformed into a holding company controlling the entire ecosystem, while Bradesco will increase its ownership to approximately 91%.

At the core of the platform sits Bradesco Saúde, which generated R$ 41 billion in revenue and R$ 3.4 billion in profit in 2025, serving 3.9 million beneficiaries. Odontoprev, Brazil’s leading dental insurer, contributed R$ 2.4 billion in revenue and R$ 550 million in net income, with a base exceeding 9 million beneficiaries and a network of 27,000 providers.

The ecosystem strategy spans the full care journey: primary care clinics under Novamed, oncology services via Croma, hospital expansion through Atlântica and digital integration driven by Orizon’s healthtech infrastructure, which connects insurers, providers and pharmacies through analytics and automation tools.

Leadership framed the move as structural rather than incremental. Luiz Carlos Trabuco Cappi, chairman of Bradesco and Odontoprev, described Bradsaúde as the most complete healthcare ecosystem in Brazil and a strategic milestone for the group. Bradesco CEO Marcelo Noronha highlighted insurance operations as one of the bank’s core profitability engines. Ivan Gontijo, head of the insurance group, emphasized the expansion opportunities in Brazil’s underpenetrated private healthcare market. Odontoprev CEO Elsen Carvalho pointed to the potential to increase dental plan penetration among small and medium-sized enterprises through Bradesco’s distribution network.

Strategically, the platform aims to reinforce leadership in health and dental plans, accelerate the expansion of Atlântica’s hospital footprint, scale oncology and primary care services, foster new businesses across the healthcare value chain and expand cross-selling through brokers and Bradesco’s financial channels. The transaction remains subject to customary closing conditions, including shareholder and regulatory approvals.

For investors, Bradsaúde represents more than a corporate simplification. It signals Bradesco’s intention to position healthcare as a standalone growth pillar — with scale, vertical integration and sustainable profitability — in one of Brazil’s most structurally resilient sectors.

New Corporate Structure

Following implementation, Odontoprev will be renamed Bradsaúde S.A. and will cease operating directly as a dental insurer. Instead, it will become a pure holding company listed on Novo Mercado, consolidating all healthcare assets of the Bradesco Organization.

The reorganization unfolds in three main steps. First, Bradesco absorbs from its insurance holding company Bradseg the stakes in Odontoprev and Bradesco Gestão de Saúde (BGS), simplifying the ownership chain. Second, Odontoprev incorporates BGS through a share swap, increasing Bradesco’s ownership in the combined entity to roughly 91%, leaving approximately 9% in public float. Third, Odontoprev transfers its operating dental portfolio to Mediservice, which will remain the regulated entity authorized by Brazil’s National Supplementary Health Agency (ANS) to operate health and dental plans.

Leave a Reply

Discover more from Brazil Stock Guide

Subscribe now to keep reading and get access to the full archive.

Continue reading